Bethesda (1)

Severe Combined Immune Deficiency (SCID) (1)

Enrolling by invitation (1)

phase 1/phase 2 (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

busulfan (1)

g-csf (1)

horse -anti-thymocyte (1)

sirolimus (1)

total body irradiation (tbi) (1)

drug (1)

radiation (1)

NIH (1)

Interventional (1)

severe combined immune deficiency (scid)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Enrolling by invitation

Aug 24, 2022